股溜產業平台

台新藥

6838上市
21.00−1.00−4.55%收盤・資料日 2026-11-06

營收與獲利單位：億元；資料到 2026 Q2

2026 Q20.03 億元−0.05 億元−0.76 億元−0.68 億元

營收與獲利（億元；單季）

21Q422Q222Q423Q223Q424Q224Q425Q225Q426Q2

損益表單位：億元（每股盈餘：元）；單季，最新在左

科目2026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q3
營業收入淨額0.030.450.030.010.050.010.060.040.051.280.000.010.31—0.01—0.00—0.00—
營業成本0.080.060.030.060.010.010.030.040.010.160.000.000.04—0.01—0.00—0.00—
營業毛利−0.050.390.01−0.050.04−0.010.030.010.041.120.000.010.27—0.00—0.00—0.00—
營業費用0.710.500.400.390.550.340.390.531.050.980.610.821.67—1.88—1.94—2.25—
推銷費用0.020.010.020.050.020.040.030.02————————————
管理費用0.080.090.070.090.080.100.060.120.270.110.100.110.19—0.14—0.11—0.11—
研究發展費用0.620.400.310.250.460.200.220.390.770.870.510.711.48—1.73—1.83—2.14—
營業利益−0.76−0.11−0.39−0.45−0.52−0.35−0.36−0.52−1.010.13−0.61−0.82−1.40—−1.88—−1.94—−2.25—
營業外收入及支出0.10−0.04−0.09−0.151.16−0.06−0.010.060.04−0.140.19−0.430.07—−0.16—−0.09—0.07—
財務成本0.000.000.000.000.000.000.000.000.000.000.000.040.00—0.01—0.00—0.00—
稅前淨利−0.65−0.15−0.48−0.590.64−0.41−0.37−0.45−0.970.00−0.43−1.25−1.33—−2.03—−2.03—−2.18—
所得稅費用0.020.000.000.000.000.000.020.010.000.190.000.190.03—0.00—0.00—0.03—
繼續營業單位損益−0.68−0.15−0.48−0.590.64−0.41−0.39−0.46−0.97−0.19−0.43−1.44−1.35—−2.03—−2.03—−2.20—
本期淨利（稅後）−0.68−0.15−0.48−0.590.64−0.41−0.39−0.46−0.97−0.19−0.43−1.44−1.35—−2.03—−2.03—−2.20—
歸屬母公司業主−0.68−0.15−0.48−0.590.64−0.41−0.39−0.46−0.97−0.19−0.43−1.44−1.36—−2.03—−2.03—−2.20—
本期綜合損益總額−0.70−0.15−0.53−0.580.59−0.39−0.56−0.38−1.30−0.35−0.36−1.54−1.44—−1.97—−2.13—−2.25—
綜合損益歸屬母公司業主−0.70−0.15−0.53−0.580.59−0.39−0.56−0.38−1.30−0.35−0.36−1.54−1.44—−1.97—−2.13—−2.25—
每股盈餘（元）−0.45−0.10−0.31−0.390.43−0.27−0.27−0.37−0.72−0.15−0.28−1.08−1.19—−1.81—−2.05—−2.24—

股溜產業平台 產業資訊整理，不構成投資建議；數字以證交所、櫃買中心、集保公告為準。 資料日 2026-11-06